Press release
P&C Solution to Showcase Advanced AR Glasses, METALENSE 2, at CES 2025
P&C Solution [https://www.pncsolution.co.kr/eng/main.php], an innovative provider of XR solutions, has announced its participation in the upcoming Consumer Electronics Show(CES) 2025, taking place from January 7th to 10th in Las Vegas. At the event, the company will unveil its latest innovation, the METALENSE 2, an advanced augmented reality (AR) glass that offers an immersive XR experience.
Building upon the success of its predecessor, the CES 2023 Innovation Award-winning METALENSE, the METALENSE 2 features a significant performance upgrade through the integration of Qualcomm's Spaces platform. With the powerful Metacore 2.0, the METALENSE 2 delivers exceptional performance and a stunning QHD (2560 x 1440) resolution, providing users with an incredibly immersive XR experience.
Designed with user comfort in mind, the METALENSE 2 boasts an ergonomic design for extended wear. Additionally, the easily replaceable battery ensures uninterrupted usage. With support for various wireless data communication methods, including LTE, users can enjoy seamless XR experiences anytime, anywhere.
Image: https://www.abnewswire.com/upload/2025/01/e118eb44ca26d307a4b2bef8d166835f.jpg
"The METALENSE 2 sets a new standard for AR glasses," said a representative from P&C Solution. "We are confident that our XR total solution will drive innovation across various industries."
P&C Solution will be showcasing the enhanced METALENSE 2 at booth #16153 in the Las Vegas Convention Center.
For more details contact P&C Solution Co., Ltd. at +82-2-528-6000/+82-70-8880-0316, email pnc@pncsolution.co.kr or visit https://www.pncsolution.co.kr/eng/main.php
Media Contact
Company Name: P&C Solution Co., Ltd.
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pc-solution-to-showcase-advanced-ar-glasses-metalense-2-at-ces-2025]
Phone: +82-2-528-6000
City: Seoul
Country: South Korea
Website: http://www.pncsolution.co.kr/eng/main.php
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release P&C Solution to Showcase Advanced AR Glasses, METALENSE 2, at CES 2025 here
News-ID: 3803320 • Views: …
More Releases from ABNewswire
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…
